CHICAGO (Reuters) - An experimental treatment in mice showed promise in reversing a rare blood disease that can cause leukemia, U.S. researchers said on Monday, offering a glimpse of how the drug may work as it begins testing in humans.
CHICAGO (Reuters) - An experimental treatment in mice showed promise in reversing a rare blood disease that can cause leukemia, U.S. researchers said on Monday, offering a glimpse of how the drug may work as it begins testing in humans.
